China’s Hebei province enters 'wartime' mode after burst of COVID-19 cases

▴ China’s Hebei province enters 'wartime' mode after burst of COVID-19 cases
The province reported 14 new confirmed locally transmitted cases and 30 asymptomatic cases today as per the provincial health commission with a total of 19 confirmed coronavirus cases and 40 asymptomatic cases since Saturday.

North China's Hebei Province, neighboring Chinese capital Beijing, enters "wartime" mode today.

The province reported 14 new confirmed locally transmitted cases and 30 asymptomatic cases today as per the provincial health commission with a total of 19 confirmed coronavirus cases and 40 asymptomatic cases since Saturday.

The Chinese mainland reported 33 new COVID-19 cases today, including 17 locally transmitted cases.

In its daily report, the National Health Commission said that of the locally transmitted cases, 14 were reported in Hebei, two in Liaoning, and one in Beijing.

Xiaoguozhuang village in Hebei’s provincial capital Shijiazhuang has been declared as a no-go zone under a full lockdown as it raised its COVID-19 emergency response level to high-risk today, becoming the only high-risk area in China at the moment after it reported eight new locally transmitted cases.

As of Tuesday, China has one high-risk area and 48 medium-risk areas, of which 32 are located in Northeast China's Liaoning Province, seven in Beijing, six in Northeast China's Heilongjiang Province, and three in Hebei.


Beijing enters the fourth week of new viral cases as municipal health authority confirmed one more case on Tuesday, bringing its tally to 993, with 40 still hospitalized.

Amid the flare-up of COVID cases in Beijing and surrounding areas, Beijing city has extended the COVID-19 observation period for inbound travelers to 21 days following sporadic locally-transmitted cases.

People will have to be in isolation or stay at home for another seven days after a 14-day observation period.

Meanwhile, inbound travelers may enter Beijing 21 days after they enter China at another port of entry.

According to the press conference, currently, a total of 2.59 million nucleic acid tests have been taken in Beijing, including the districts of Shunyi and Chaoyang, since a rebound in indigenous cases.

Tags : #ChinasCovid19Updates #China #NewCovid-19Patients #NewCovid-19Cases #ChineseHealthCommission #Hebei #Beijing #Covid-19NewStrain #ChinaCovidUpdates06Jan2021

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024